129
Participants
Start Date
June 1, 2024
Primary Completion Date
June 30, 2024
Study Completion Date
July 1, 2024
Sitagliptin and Gliclazide
Participants in this arm will receive sitagliptin phosphate 100 mg once daily combined with gliclazide sustained-release tablets 30-120 mg once daily for 12 weeks
Metformin
Participants in this arm will receive metformin 500 mg to 2000 mg per day, divided into two doses, for 12 weeks
Nanfang Hospital, Southern Medical University, Guangzhou
Nanfang Hospital, Southern Medical University
OTHER
Zhibin Xu
OTHER